MedPath

Percutaneous Radiofrequency ablation for Pulmonary Metastasis from Colorectal Cancer: Phase II Clinical Trial

Not Applicable
Conditions
Pulmonary metastasis from colorectal cancer
Registration Number
JPRN-UMIN000014391
Lead Sponsor
Department of Radiology, Okayama University Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1)Lack of safe needle insertion path. 2)RFA is considered to be de hazardous because of critical organs close to the target lesion. 3)Presence of sever comorbidities. 4)Presence of uncontrolled other malignant diseases. 5)Presence of peritoneal dissemination and/or malignant ascites. 6)Fever higher than 38-Celsius degree. 7)Severe impairment of contralateral pulmonary function. 8)Presence of pulmonary hypertension. 9)Presence of interstitial pneumonia. 10)Usage of anticoagulants and antiplatelet agents. 11)Pregnant patients. 12)Patients who are considered to be unsuitable for inclusion by physicians due to other reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath